Michael Tirgan

Dr. Michael Tirgan

Tirgan BioPharmaceuticals

2013-2014

Focusing on developing new drugs for treatment of Keloid Disorder: 1) reformulating a generic drug into a sustained release product using nano-technology; 2) purifying plant extract to create a new topical cream.

Newsletter Signup

Corporate Supporters

Community Service Providers